Last week, the 68th session of the United Nations Commission on Narcotic Drugs (CND) voted almost unanimously to place hexahydrocannabinol (HHC) under Schedule II of the...
The concept of the medical cannabis card originated out of the US in some jurisdictions where patients are issued an annual card from their doctor which...
Written by SOMAÍ Pharmaceuticals CEO, Michael Sassano For years, medical cannabis has been treated as a commodity, with little emphasis on brand differentiation. However, as the...
In a survey of 250 practicing doctors in the UK, 84% said they would be open to prescribing if it was part of the NHS toolkit.
The preliminary findings from Switzerland’s seven active pilot trials, involving around three per cent of the country’s active cannabis consumers, have been published by a local university....
One family is calling for protections for patients travelling to the country with prescribed medical cannabis.
UK medical cannabis clinic, Releaf, is investing in an ambitious new research programme to collect critical real-world evidence on the effects of medical cannabis treatments. Could...
Switzerland has approved a draft proposal to establish a fully commercial adult-use cannabis market.
Cannabis clinics can play a crucial role in changing this landscape by setting high professional standards and ensuring patients receive the same level of care as...
A new research agreement has been signed between the University of Malta and the Authority for the Responsible Use of Cannabis.
